Newsroom | 106 results

Sorted by: Latest

Aerospace
-

ADDING MULTIMEDIA NC Test: CQN Asset Order

SEATTLE--(BUSINESS WIRE)--Testing multimedia asset order during revision: First send release with BWC-uploaded MM Next, send SUPPLEMENT to add MM If needed, send Cosmetic CQN to fix asset order  ...
-

NC TEST: Overwriting a Saved Logo (2.1)

SEATTLE--(BUSINESS WIRE)--Overwriting published saved logo with a new logo (before xmit this time) to see if it correctly updates on this order and the client MM library....
-

NC Testing Email Send Before Language Line

SEATTLE--(BUSINESS WIRE)--Trying to split Sales Order then recombine after sending....
-

CORRECTING and REPLACING NC Test Announces Commencement of Tender Offer for 6.140% Senior Unsecured Notes Due 2025

NEW YORK--(BUSINESS WIRE)--The percentage for the Senior Unsecured Notes in the headline, first paragraph of the release, and the first column of the table should be 6.140% instead of 6.250%. The updated release reads: CORRECTING and REPLACING NC Test Announces Commencement of Tender Offer for 6.140% Senior Unsecured Notes Due 2025 NC Test (NYSE: NKC) (“NKC”) announced today that it has commenced a cash tender offer (the “Tender Offer”) for up to $275 million of NKC’s $550 million in aggregate...
-

NC Test Attending 36th Annual Roth Capital Conference

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--NC Test (the “Company”) is a North American energy company with rapidly growing oil production in Oklahoma and low leverage. The Company has substantial reserves with 60 proved drilling locations and 180 proved, probable, and possible locations from the Company’s December 31, 2022 third-party reserve report. The Company is listed on the NASDAQ, ticker NKC, as well as on the TSX, ticker NKC. The Company is pleased to announce that it will attend the 36th A...
-

NC/SE TEST: PDF and Photo Assets, CQN with Same File Names

SEATTLE--(BUSINESS WIRE)--Testing a PDF correction with the same file name....
-

Vergent Bioscience Presents Phase 2 Data Showing VGT-309 Visualizes Tumors in the Lung During Surgery

MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced new data presented today at the 60th Annual Meeting of The Society of Thoracic Surgeons (#STS24). The data demonstrate that VGT-309, the company’s investigational tumor-targeted fluorescent imaging agent, visualizes primary and metastatic tumor tissue in the lung during surgery. The findings reinforce results from earlier clinical trials of VGT-309 which s...
-

Business Wire Test Account UK Regulatory Announcement: Official List Notice (UKLA use only) TESTtest Testing, Inc.  Results for the Year Ended 31 December 1776

LONDON--(BUSINESS WIRE)--  The directors of TESTtest Testing, Inc. announce the company’s preliminary unaudited results for the year ended 31 December 1776. These have been released in conjunction with the circular sent to shareholders as at the same date of this announcement and the further announcement setting out the Company’s intention to withdraws its securities from the FOX Exchange and pursue preparations to return capital to shareholders by way of a solvent liquidation. The Directors of...
-

Egypt Test

SEATTLE--(BUSINESS WIRE)--Is the time correct?...
-

NC Twitter Test

SEATTLE--(BUSINESS WIRE)--Testing Twitter visibility in sidebar when entered in both the Twitter field and social media list in BWC....